Preview Mode Links will not work in preview mode

Jan 22, 2022

Featuring perspectives from Drs Alice Mims, Alexander Perl, Richard Stone and Geoffrey Uy, moderated by Dr Harry Paul Erba, including the following topics:

  • Introduction (0:00)
  • Front-Line Treatment for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Therapy (4:15)
  • Induction and Maintenance Therapy Options for Younger Patients with AML and No Targetable Mutations (28:42)
  • Optimal Treatment Approaches for AML with Targetable Mutations (49:26)
  • Management of Secondary AML; New Directions in AML Care (1:11:18)
  • Current and Future Management Approaches for Myelodysplastic Syndromes (1:34:39)

CME information and select publications